Western Development Commission
VC Fund
Ballaghaderreen, Ireland
Western Development Commission (WDC) is a government institution that offers economic and social development services to Galway, Clare, Mayo, Roscommon, Donegal, Leitrim, and Sligo counties. It provides employment creation; population growth, employment patterns, education levels, and social exclusion analysis; and infrastructure developmentservices. Additionally, the commission offers telecommunication, public transport, and renewable energy sectors development services in rural areas. It also provides business development services in rural tourism, marine, technology, and organic agriculture sectors. WDC was founded in 1997 and is based in Ballaghaderreen, Ireland.
- Total investments:
- 45
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries Western Development Commission invests in
Stages Western Development Commission invests in
Countries Western Development Commission invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $702k–$3.9M
- Venture - Series Unknown
- $753k–$17M
Investment Focus
Industry
- Health Care 14 (31%)
- Medical Device 14 (31%)
- Biotechnology 7 (16%)
- Medical 6 (13%)
- Information Technology 4 (9%)
Stage
- Seed 17 (38%)
- Funding Round 7 (16%)
- Venture - Series Unknown 7 (16%)
- Series A 6 (13%)
- Grant 1 (2%)
Country
- Ireland 32 (71%)
- United States 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Allan Mulrooney
Interim Chief Executive Officer
|
Interim Chief Executive Officer | Total investments: 2 | Find email | |
Ian Brannigan
Head of Regional Development
|
Head of Regional Development | Total investments: 0 | Find email | |
|
Patricia Teatum
Head Of Corporate Services
|
Head Of Corporate Services | Total investments: 0 | Find email | |
Tomas Siochain
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Galway Biomedical
|
Galway Biomedical develops and manufactures medical devices. | Series A / Apr 23, 2025 | |
Ovagen
|
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics. | $2.2M / Series A / Oct 29, 2024 | |
|
Ovagen
|
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics. | $2.2M / Series A / Oct 29, 2024 | |
Peroptyx
|
Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts. | $1.1M / Seed / Jul 10, 2024 | |
CitySwift
|
CitySwift is a data-driven scheduling and planning technology for urban bus networks. The company uses artificial intelligence and machine learning to predict journey times and passenger demand, making routes more efficient. Schedulers can create optimized timetables that take into account traffic, events, and hundreds of other external factors,ensuring on-time performance and increased passenger satisfaction.CitySwift was established on September 1, 2016 by Alan Farrelly and Brian O'Rourke in Galway, Ireland.CitySwift was established in 2016 and is operating in Galway, Ireland. | $7.6M / Venture - Series Unknown / Feb 01, 2024 | |
FeelTect
|
FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous. | $1.6M / Dec 20, 2023 | |
|
FeelTect
|
FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous. | $1.6M / Seed / Dec 20, 2023 | |
Amara Therapeutics
|
Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform. | $1.6M / Seed / May 08, 2023 | |
Bluedrop Medical
|
It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.5M / Mar 31, 2023 | |
|
Bluedrop Medical
|
It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.4M / Seed / Mar 31, 2023 | |
| See all 45 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Western Development Commission invest in?
Western Development Commission invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 45 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Western Development Commission's check size?
Western Development Commission typically joins rounds of $702k–$3.9M at Seed and $753k–$17M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Western Development Commission participates in.
How do I contact Western Development Commission?
Public channels for Western Development Commission include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Western Development Commission?
The team at Western Development Commission includes Allan Mulrooney (Interim Chief Executive Officer), Ian Brannigan (Head of Regional Development) and Patricia Teatum (Head Of Corporate Services). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
